Clinical Roundup Exercise during chemotherapy for breast cancer improves quality of life, Sylvester-led study finds February 27, 2026Vol.52 No.08
Clinical Roundup Follicular lymphoma may be curable with chemoimmunotherapy combo, data from 15-year trial suggests February 27, 2026Vol.52 No.08
Clinical Roundup ARPA-H opens first interventional clinical trials to outpace cancer in real time February 20, 2026Vol.52 No.07
Clinical Roundup Cancer cells’ ability to adapt could yield new treatment approaches, NYU-led study finds February 20, 2026Vol.52 No.07
Clinical Roundup NCCN guidelines detail fundamental differences between pediatric and adult cancers February 20, 2026Vol.52 No.07
Clinical Roundup Findings from Cincinnati Children’s study could make immune checkpoint inhibitors safer February 20, 2026Vol.52 No.07
Clinical Roundup Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer February 20, 2026Vol.52 No.07
Clinical Roundup Mount Sinai study strengthens evidence supporting lung-sparing surgery in mesothelioma February 20, 2026Vol.52 No.07
Clinical Roundup Lung cancer drug offers a surprising new treatment against ovarian cancer, Mayo study finds February 20, 2026Vol.52 No.07
Clinical Roundup Different KRAS mutations affect how tumors interact with the immune system, UTSW-led study finds February 20, 2026Vol.52 No.07
